Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05154071

Acronym

ECMO UNIT

Enrollment

172

Registered

2021-12-10

Start date

2021-10-01

Completion date

2021-12-01

Last updated

2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation

Brief summary

Current evidence suggest that regrouping patient supported by veno-venous ECMO in high-volume centre could improve outcome. A dedicated ECMO unit was implemented in Dijon. The objective of the present study was to evaluate the implementation of this unit. The hypothesis was that patient taken care within this structured care system would have lower mortality. This research comprises a retrospective observational study conducted in Dijon university hospital

Interventions

OTHERCollection of medical data

Collection of adverse events, of mortality, length of hospitalization

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient in an adult Dijon ICUs supported by veno-venous ECMO * patient hospitalized between January the 1st 2011 and June the 30th 2021

Exclusion criteria

* Refusal to participate, * patient admitted to pediatric ICU

Design outcomes

Primary

Measure	Time frame
Mortality rate	90 days

Secondary

Measure	Time frame
Rate of ECMO adverse events	through study completion, an average of 3 years
Hospital length of stay	through study completion, an average of 3 years
ICU length of stay	through study completion, an average of 3 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026